Correlation Between Anebulo Pharmaceuticals and Immunome
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Immunome, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Immunome.
Diversification Opportunities for Anebulo Pharmaceuticals and Immunome
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Anebulo and Immunome is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Immunome go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Immunome
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Immunome. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.06 times less risky than Immunome. The stock trades about -0.19 of its potential returns per unit of risk. The Immunome is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 969.00 in Immunome on November 27, 2024 and sell it today you would lose (2.00) from holding Immunome or give up 0.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Immunome
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Immunome |
Anebulo Pharmaceuticals and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Immunome
The main advantage of trading using opposite Anebulo Pharmaceuticals and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |